News & Publications for:

Randall Bateman

Randy Bateman, John Morris receive $4.2 million to accelerate Alzheimer’s trials

Posted on March 20, 2012

Alzheimer’s Association support for the Dominantly Inherited Alzheimer’s Network (DIAN) Therapeutic Trials Unit. Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, News, Therapeutics & Diagnostics Faculty: ,

Marker for Alzheimer’s disease rises during day, falls with sleep

Posted on November 2, 2011

Levels of amyloid beta in spinal fluid oscillate with the sleep/wake cycle. Read More

Posted in: News Faculty:

Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance

Posted on October 12, 2011

Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, Bales KR, Paul SM, Bateman RJ, Holtzman DM (2011). Science Translational Medicine, 3(89):89ra57 Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, Publications, Therapeutics & Diagnostics Faculty: , , , , , ,

Autosomal-dominant Alzheimer’s disease: a review and proposal for the prevention of Alzheimer’s disease

Posted on October 10, 2011

Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C (2011). Alzheimers Res Ther, 2(6):35. PMCID:PMC3109410 Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, Publications, Therapeutics & Diagnostics Faculty: